Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine as the Main Analgesic Agent During Analgesia-based Sedation for Elective Colonoscopy
NCT05421962Phase 1Completed
- Sponsor
- Cantonal Hospital Zenica
- Start
- Jan 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ketamine in pain (3 arms), sponsored by Cantonal Hospital Zenica. Primary endpoint: Visual Analog Scale for Pain. Started Jan 2020; status: completed.
02
Drugs
ketamine
03
Conditions
pain
Beyond the preview
Go deeper on NCT05421962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05421962.